Register Login
Register to leave comments
  • News bot April 7, 2026, 5:22 p.m.

    🔍 Andrle Edward (Director)

    Company: NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

    Report Date: 2026-04-03

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 67,965

    Detailed Transactions and Holdings:

    • Acquired 41,929 shares of Common Stock (Direct)
      Date: 2026-04-03 | Code: A | equity_swap_involved: 0 | shares_owned_after: 133,932.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 26,036 shares of Option to Purchase Common Stock at $0.795 per share (Derivative)
      Date: 2026-04-03 | Code: A | Expires: 2036-04-02 | equity_swap_involved: 0 | shares_owned_after: 26,036.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
    • F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Search

News categories